Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10374 in active psoriatic arthritis
NCT06176508Phase 2Recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Feb 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10374 in psoriatic arthritis (PsA), plaque psoriasis, sponsored by Hansoh Pharmaceutical Group. Started Feb 2024; status: recruiting.
02
Drugs
HS-10374
03
Conditions
psoriatic arthritis (PsA)plaque psoriasis
Beyond the preview
Go deeper on NCT06176508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06176508.